SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.93+2.9%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (7801)11/24/1998 12:17:00 PM
From: aknahow  Read Replies (1) of 17367
 
BLUEGREEN, another link from the same previous Bermuda site gives more information on why many choose Bermuda. Wish that GregoryP had not made the comment about something smelling. Trying to be civil to him. If someone else had said it I would have recommended taking their head out of their ass.

bermuda-online.com

Seems logical to consider this move. Your post said what I was thinking. In addition, good management thinks ahead. Neuprex may never be approved, but XOMA would have egg on its' face if it waited for approval before making any decisions. For example management knows that if Neuprex is approved they will have to manufacture it. Does anyone think a company gears up for manufacturing only after approval is obtained?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext